• Deployment of 500 additional 3DICOM MD® licences to Provider Network Solutions
• Payment of USD$500,000 from PNS as per Binding Enterprise Agreement
• Commenced discussions with PNS regarding expansion and renewal of licensing arrangements

The March quarter represented a period of strong execution for Singular Health, with key milestones achieved across commercial deployment, education partnerships, regulatory engagement, and governance maturity. Singular Health's commercial agreement with Provider Network Solutions (PNS) continued to progress well, with the deployment of an additional 500 3DICOM MD® licences and the receipt of a USD$500,000 payment. Singular Health also commenced discussions with PNS regarding expansion and renewal of licensing arrangements. The company successfully transitioned pilot programs into live clinical deployments, expanded its presence within the U.S. education sector, and strengthened its position within emerging regulatory and interoperability frameworks. Singular Health achieved FDA 510(k) clearance for its 3DICOM MD® Cloud platform and participated in the U.S. ONC interoperability consultation. The company also completed a voluntary, independent information security threat and risk assessment, which confirmed a strong governance and control framework. Singular Health continued to engage actively with the investment community and expects continued strong progress across its U.S. initiatives, including advanced-stage commercial discussions with a U.S. health plan.

Singular Health expects to execute a contract with a U.S. health plan in the near term, which the company believes will set the scene for a scalable deployment pipeline throughout the U.S. via the health plan's broader network. This is anticipated to solidify contract discussions with other payers within the PNS network and joint venture network nationwide.

Singular Health is highly confident in the strategic significance of the potential U.S. health plan contract and its ability to deliver long-term commercial value to payers on a scalable basis nationally in the U.S. and internationally. The company also expects continued strong progress across its other U.S. initiatives, including the PNS deployment and education partnerships.